Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx Pharmaceuticals (HEMO) Share Price

Price 644.00p on 13-01-2026 at 19:40:06
Change 7.00p 1.11%
Buy 646.00p
Sell 630.00p
Last Trade: Unknown 1,500.00 at 638.00p
Day's Volume: 20,885
Last Close: 638.00p
Open: 612.00p
ISIN: GB00BQVXM815
Day's Range 612.00p - 654.00p
52wk Range: 124.50p - 1,790.00p
Market Capitalisation: £38.91m
VWAP: 642.79685p
Shares in Issue: 6.04m

Hemogenyx Pharmaceuticals (HEMO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 1,500 638.00p OTC Trade
17:07:25 - 13-Jan-26
Buy* 130 644.00p Automatic Execution
16:22:26 - 13-Jan-26
Sell* 467 636.2362p Ordinary
16:09:53 - 13-Jan-26
Buy* 4 643.7375p Ordinary
15:53:07 - 13-Jan-26
Unknown* 0 652.00p SI Trade
15:34:13 - 13-Jan-26
Buy* 115 652.00p Automatic Execution
15:34:13 - 13-Jan-26
Sell* 500 641.6767p Ordinary
15:23:38 - 13-Jan-26
Buy* 1 652.00p SI Trade
15:22:13 - 13-Jan-26
Unknown* 0 630.00p SI Trade
14:17:28 - 13-Jan-26
Buy* 178 651.90p Ordinary
14:09:05 - 13-Jan-26
See more Hemogenyx Pharmaceuticals trades

Hemogenyx Pharmaceuticals (HEMO) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Jan 2026 (Tue) 612.00 654.00 612.00 638.00 20,885
12th Jan 2026 (Mon) 618.00 642.00 600.00 631.00 27,984
9th Jan 2026 (Fri) 624.00 624.00 621.00 621.00 13,466
8th Jan 2026 (Thu) 648.00 648.00 602.00 624.00 39,936
7th Jan 2026 (Wed) 602.00 660.00 592.00 610.00 42,799
6th Jan 2026 (Tue) 578.00 578.00 546.00 578.00 19,906
5th Jan 2026 (Mon) 574.00 606.00 548.00 548.00 12,654
2nd Jan 2026 (Fri) 552.00 610.00 552.00 568.00 23,497
1st Jan 2026 (Thu) 572.00 572.00 572.00 572.00 0
31st Dec 2025 (Wed) 592.00 592.00 550.00 572.00 3,116
30th Dec 2025 (Tue) 556.00 574.00 550.00 570.00 15,762
29th Dec 2025 (Mon) 582.00 582.00 564.00 568.00 21,020
26th Dec 2025 (Fri) 596.00 596.00 596.00 596.00 0
25th Dec 2025 (Thu) 596.00 596.00 596.00 596.00 0
24th Dec 2025 (Wed) 596.00 596.00 596.00 596.00 985
23rd Dec 2025 (Tue) 628.00 628.00 582.00 600.00 16,664
22nd Dec 2025 (Mon) 616.00 634.00 550.00 634.00 45,707
19th Dec 2025 (Fri) 608.00 608.00 598.00 598.00 15,285
18th Dec 2025 (Thu) 602.00 670.00 602.00 643.00 23,651
17th Dec 2025 (Wed) 660.00 664.00 640.00 664.00 23,865
16th Dec 2025 (Tue) 612.00 656.00 602.00 626.00 35,075
15th Dec 2025 (Mon) 600.00 668.00 584.00 635.00 70,722
See more Hemogenyx Pharmaceuticals price history

Hemogenyx Pharmaceuticals (HEMO) Regulatory News

Date Source Headline
12th Jan 2026 7:00 am RNS Holding(s) in Company
22nd Dec 2025 8:00 am RNS Update on Admission of Shares
18th Dec 2025 7:00 am RNS Issue of Equity
8th Dec 2025 12:48 pm RNS Holding(s) in Company
28th Nov 2025 7:00 am RNS Total Voting Rights
19th Nov 2025 11:47 am RNS Publication of Prospectus
29th Oct 2025 7:00 am RNS Clinical Trial Update and Grant of Share Awards
6th Oct 2025 7:00 am RNS Clearance to Initiate Pediatric Enrolment
30th Sep 2025 7:00 am RNS Half-year Report
30th Sep 2025 7:00 am RNS Total Voting Rights
See more Hemogenyx Pharmaceuticals regulatory news

Hemogenyx Pharmaceuticals (HEMO) Share News

Hemogenyx secures clearance for pediatric enrolment in leukemia trial

6th Oct 2025 14:22

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Hemogenyx says exploring commercialisation of treatment for leukaemia

23rd Sep 2025 15:51

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it is has signed a letter of intent with Cellin Technologies OU, a Tallinn-based cell therapy company. Read More

Hemogenyx shares jump as third patient treated for leukaemia form

17th Sep 2025 11:54

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said the third patient has been successfully treated in an ongoing phase 1 clinical trial for a form of leukaemia. Read More

Hemogenyx inks manufacturing partnership deal with Made Scientific

8th Sep 2025 16:27

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has agreed a manufacturing partnership with US-based cell therapy contract development and manufacturing organisation Made Scientific. Read More

See more Hemogenyx Pharmaceuticals news
FTSE 100 Latest
Value10,137.35
Change-3.35

Login to your account

Forgot Password?

Not Registered